Parallel Advisors, LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$48,065
+39.7%
1,771
+58.3%
0.00%
+100.0%
Q2 2023$34,398
+5.6%
1,119
+23.8%
0.00%0.0%
Q1 2023$32,571
+405.6%
904
+454.6%
0.00%
Q4 2022$6,442
-57.1%
163
-56.8%
0.00%
-100.0%
Q3 2022$15,000
+114.3%
377
+116.7%
0.00%
Q2 2022$7,000
-36.4%
174
-40.8%
0.00%
Q1 2022$11,000
+10.0%
294
+13.1%
0.00%
Q4 2021$10,000
+900.0%
260
+642.9%
0.00%
Q3 2021$1,000350.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders